PBM stock news
This page provides real-time market news, earnings updates, and company announcements related to Psyence Biomedical Ltd. (PBM).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-13 19:43 EST
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway
Finviz2026-02-13 23:34:03
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders
Finviz2026-02-17 14:18:04
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
Finviz2026-02-20 22:21:43
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
Finviz2026-03-03 14:19:09
PBM stock chart
PBM stock detailsPBM stock price change
On the last trading day, PBM stock closed at 2.46 USD, with a price change of -1.20% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more